Aproximación en la evaluación, mediante un meta análisis, de eventos adversos asociados al tratamiento de pacientes con cáncer de mama

Abstract

Breast cancer is the most frequent type of cancer and the most common cause of death from cancer in women worldwide, which is why several types of treatment have been identified and documented, however, the chronic use of them generates adverse events that can worsen the clinical condition. In order to identify the proportion of adverse events reported in patients who had treatment with the CLEOPATRA protocol, a meta-analysis was carried out in order to calculate the mean effect size in terms of the proportion of patients who can reach to present an adverse event due to the use of these medications.